Increased risk of depression and impairment in quality of life in patients with lamellar ichthyosis


Por: Cortes, Hernan, Rojas-Marquez, Martin, Reyes-Hernandez, Octavio D., Morales-Morfin, Juan C., Guapillo-Vargas M.R.B., Varela-Cardoso, Miguel, Magaña J.J., Leyva-Gomez, Gerardo, Gonzalez-del Carmen, Manuel

Publicada: 1 ene 2021
Resumen:
Lamellar ichthyosis (LI) is a genetic skin disorder characterized by dark brown scales, palmoplantar hyperkeratosis, pain, and itching. LI severity could have implications in psychological aspects, causing depression and impairment in the quality of life (QoL) of patients. In this study, we used the Congenital Ichthyosis Severity Index, the Depression Beck Inventory-II (DBI-II), and the Dermatologic Life Quality Index (DLQI) to assess severity, level of depression, and impairment in QoL in a group of patients with LI. We observed that the majority of the patients presented a high severity level concerning the presence of scales (57.7%), while for erythema and alopecia, the severity was less 80% of the analyzed patients presented depression, while only 20.8% of individuals of the control group presented it (P < .001, OR = 15.2). While for QoL, only 4.3% of the patients did not exhibit any impairment. Finally, the increase in the score obtained in DBI-II was correlated with the DLQI score (rs = 0.663, P = .0014). Our results suggest that patients with LI have an increased risk of suffering depression and impairment in their QoL; thus, the management of their disease should be performed from a multidisciplinary perspective to improve the global aspects of their lives.

Filiaciones:
Cortes, Hernan:
 Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de Mexico, Mexico

Rojas-Marquez, Martin:
 Hospital Psiquiátrico Infantil Dr. Juan N. Navarro, Secretaría de Salud, Ciudad de México, Mexico

Reyes-Hernandez, Octavio D.:
 Laboratorio de Biología Molecular del Cáncer, UMIEZ, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Ciudad de México, Mexico

Morales-Morfin, Juan C.:
 Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de Mexico, Mexico

Guapillo-Vargas M.R.B.:
 Facultad de Ciencias Químicas, Universidad Veracruzana, Veracruz, Mexico

Varela-Cardoso, Miguel:
 Facultad de Medicina, Universidad Veracruzana, Veracruz, Mexico

Magaña J.J.:
 Laboratorio de Medicina Genómica, Departamento de Genómica, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Ciudad de Mexico, Mexico

 Escuela de Ingeniería y Ciencias, Departamento de Bioingeniería, Tecnológico de Monterrey Campus Ciudad de México, Ciudad de México, Mexico

Leyva-Gomez, Gerardo:
 Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, Mexico

Gonzalez-del Carmen, Manuel:
 Facultad de Medicina, Universidad Veracruzana, Veracruz, Mexico
ISSN: 13960296





DERMATOLOGIC THERAPY
Editorial
Blackwell Publishing Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Estados Unidos America
Tipo de documento: Article
Volumen: 34 Número: 1
Páginas:
WOS Id: 000598404100001
ID de PubMed: 33277959